Get the Stockscreener App
23.45
2.01%
-0.48
After Hours:
23.45
Tectonic Therapeutic Inc stock is traded at $23.45, with a volume of 225.70K.
It is down -2.01% in the last 24 hours and up +15.12% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$23.93
Open:
$24.12
24h Volume:
225.70K
Relative Volume:
0.61
Market Cap:
$438.90M
Revenue:
-
Net Income/Loss:
$-67.30M
P/E Ratio:
-6.0903
EPS:
-3.8504
Net Cash Flow:
$-62.65M
1W Performance:
+9.73%
1M Performance:
+15.12%
6M Performance:
-11.71%
1Y Performance:
-8.29%
1-Day Range:
$22.82
$24.30
1-Week Range:
$20.95
$24.65
52-Week Range:
$13.70
$27.33
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
23.45 | 447.88M | 0 | -67.30M | -62.65M | -3.8504 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Sep-03-25 | Initiated | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - Yahoo Finance
Tectonic Therapeutic Announces Leadership Transition and New Chair - TipRanks
Insider Trends: Is now the right time to enter Tectonic Therapeutic IncDollar Strength & Daily Entry Point Alerts - baoquankhu1.vn
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - citybiz
Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board - TradingView
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board - Bitget
Aberdeen Group plc Takes $5.59 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
What are Tectonic Therapeutic Inc.’s technical support levels2025 Winners & Losers & Community Consensus Trade Signals - mfd.ru
Is Tectonic Therapeutic Inc. stock a smart retirement pickJuly 2025 Gainers & Free Community Consensus Stock Picks - mfd.ru
Market Outlook: Will KINS stock hit new highs in YEAREarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
Published on: 2026-02-16 17:45:36 - baoquankhu1.vn
Can Tectonic Therapeutic Inc. stock double in the next yearLayoff News & Real-Time Stock Entry Alerts - mfd.ru
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic - Yahoo Finance
Is Tectonic Therapeutic Inc. subject to activist investor interest2025 Biggest Moves & Entry Point Confirmation Signals - mfd.ru
Will Tectonic Therapeutic Inc. benefit from rate cutsJuly 2025 Summary & High Accuracy Investment Entry Signals - mfd.ru
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years - Sahm
What are analysts’ price targets for Tectonic Therapeutic Inc.July 2025 Retail & Reliable Entry Point Trade Alerts - mfd.ru
Is Tectonic Therapeutic Inc. stock a falling knife or bargain buy2025 Major Catalysts & AI Optimized Trading Strategy Guides - mfd.ru
Insider Buying: Daniel Lochner Acquires Additional Shares of Tec - GuruFocus
Tectonic Therapeutic (NASDAQ:TECX) CFO Daniel Lochner Purchases 6,000 Shares - MarketBeat
Tectonic Therapeutic to Host Virtual KOL Event and - GlobeNewswire
What are Tectonic Therapeutic Inc.’s recent SEC filings showingQuarterly Market Summary & Accurate Technical Buy Alerts - mfd.ru
What’s the analyst consensus on Tectonic Therapeutic Inc.Portfolio Value Report & Real-Time Stock Entry Alerts - mfd.ru
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aug Patterns: Is Tectonic Therapeutic Inc subject to activist investor interestWeekly Volume Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
What is Lifesci Capital's Forecast for TECX FY2025 Earnings? - MarketBeat
What is Lifesci Capital’s Forecast for TECX FY2025 Earnings? - Defense World
Risk Hedge: Does Tectonic Therapeutic Inc have declining or rising EPS2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Aug Selloffs: Does Tectonic Therapeutic Inc have declining or rising EPSMarket Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Lifesci Capital Upgrades Tectonic Therapeutic (NASDAQ:TECX) to “Strong-Buy” - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
S P Trends: Is Tectonic Therapeutic Inc stock a smart retirement pickExit Point & Daily Profit Focused Screening - baoquankhu1.vn
Aug Sentiment: Can Tectonic Therapeutic Inc. outperform under higher oil prices2025 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Retail: Is Tectonic Therapeutic Inc subject to activist investor interestPortfolio Update Summary & Safe Entry Point Identification - baoquankhu1.vn
IPO Launch: What is the PEG ratio of Tectonic Therapeutic Inc2025 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn
Insiders In Tectonic Therapeutic Still Down 37% On US$51.1m Investment - simplywall.st
Aug Movers: What is STROs market positionJuly 2025 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Is now the right time to enter Tectonic Therapeutic IncMarket Growth Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 277% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Breakouts Watch: Is Sprott Focus Trust Inc in a consolidation phase2025 Key Highlights & Real-Time Price Movement Reports - baoquankhu1.vn
Published on: 2026-01-26 00:19:05 - baoquankhu1.vn
Can Tectonic Therapeutic Inc lead its sector in growthQuarterly Trade Report & Verified Entry Point Detection - baoquankhu1.vn
Tectonic Therapeutic Reports Q3 2025 Financial Results - MSN
Stock Report: What is Westwater Resources Incs valuation compared to sectorEarnings Risk Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tectonic Therapeutic Inc Stock (TECX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):